ArticleMolecular biology reports2026
Comparative effects of aerobic exercise in early versus late middle age on skeletal muscle function and miRNA profiling in mice.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSkeletal muscle plasticity progressively declines from middle age onward, and exercise may partially mitigate this deterioration through microRNA (miRNA)-mediated regulatory networks. However, whether the timing of aerobic exercise initiation during middle age (early vs. late) differentially influences muscle function and miRNA expression profiles remains incompletely understood. METHODS AND
resultsMale C57BL/6 mice were assigned to four groups: middle-aged control (MC, 12 months), old-aged control (MC18, 18 months), early exercise (PRE18, 12-15 months), and late exercise (POS18, 15-18 months). Gastrocnemius muscles were collected for miRNA sequencing and subsequent functional analyses. The MC18 group exhibited sarcopenic-like phenotypes, with 176 differentially expressed miRNAs (DEmiRNAs) identified relative to the MC group. Aerobic exercise was associated with attenuation of age-related muscle atrophy, with PRE18 showing comparatively more pronounced effects than POS18. miRNA sequencing identified 21 DEmiRNAs with reversed expression patterns in the PRE18 group, whereas only 2 such miRNAs were identified in the POS18 group. Bioinformatic analysis of predicted targets suggested that early-exercise-induced miRNAs may be involved in suppressing FOXO/ubiquitin-mediated proteolysis and restoring Wnt/cAMP signaling, whereas late-exercise-induced miRNAs appeared to have a limited capacity to restore Wnt signaling. miR-195a-5p_R+1, miR-298-5p_R-2, miR-671-5p_R+1 and miR-150-5p were identified as candidate hub miRNAs based on target enrichments within these pathways. Western blot analyses indicated that PRE18 was associated with elevated expression of Wnt‑related (β‑catenin) and cAMP‑related (CREB1, PGC‑1α) proteins, alongside reduced levels of atrophic markers (FOXO3A, FBXO32, and MuRF1). In contrast, POS18 primarily affected atrophic protein expression, with relatively modest influence on Wnt signaling components.
conclusionsThese preliminary findings collectively suggest that the sustained benefits of exercise initiated in early middle age might be partially attributable to exercise‑induced miRNAs dually targeting both regenerative and atrophic pathways. Conversely, late initiation appears to be predominantly linked to anti‑atrophic effects, with less impact on regenerative signaling. Together, these observations provide initial evidence for temporal epigenetic plasticity and suggest broader molecular advantages of earlier intervention, although further mechanistic studies are warranted.
Indexed as
Identifiers
42550391What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.